GlassScriptPhysician profile
Rupa Patel
NPI 1801329057
$1,234.88
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $396 · 2022: $472 · 2023: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $209.11 | 2021-2023 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.68 | 2021-2023 | Tradjenta, Jardiance, Synjardy |
| Lilly USA, LLC | $164.87 | 2021-2023 | Mounjaro |
| W. L. Gore & Associates, INC. | $152.34 | 2023 | Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Astrazeneca Pharmaceuticals LP | $131.48 | 2021-2023 | Farxiga |
| Glaxosmithkline, LLC. | $106.68 | 2021-2023 | Shingrix |
| Abbott Laboratories | $61.46 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $34.59 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $32.94 | 2021-2022 | |
| Itamar Medical INC | $28.72 | 2022 | |
| Abiomed | $26.17 | 2023 | Impella |
| Hologic Sales and Service, LLC | $22.28 | 2021 | |
| Abbvie INC. | $16.65 | 2021 | |
| Merck Sharp & Dohme LLC | $15.09 | 2021 | |
| Currax Pharmaceuticals LLC | $14.87 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.51 | 2022 | |
| Ibsa Pharma INC. | $13.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rupa Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.